National Research Corp. (NASDAQ:NRCIB) CEO Michael D. Hays sold 3,533 shares of the business’s stock in a transaction that occurred on Monday, September 19th. The stock was sold at an average price of $16.19, for a total value of $57,199.27. Following the transaction, the chief executive officer now owns 6,467,744 shares of the company’s stock, valued at $104,712,775.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

National Research Corp. (NASDAQ:NRCIB) traded up 1.6323% during midday trading on Wednesday, reaching $36.1811. The company’s stock had a trading volume of 236 shares. The firm has a 50-day moving average price of $33.92 and a 200 day moving average price of $35.16. The stock has a market capitalization of $876.34 million, a price-to-earnings ratio of 44.4485 and a beta of 0.28. National Research Corp. has a 52-week low of $31.36 and a 52-week high of $44.60.

National Research Corp. (NASDAQ:NRCIB) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $0.18 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.18. National Research Corp. had a net margin of 18.75% and a return on equity of 33.74%. Equities research analysts predict that National Research Corp. will post $0.82 EPS for the current fiscal year.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Investors of record on Friday, September 30th will be given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 5.31%. The ex-dividend date of this dividend is Wednesday, September 28th. National Research Corp.’s dividend payout ratio is 408.52%.

An institutional investor recently bought a new position in National Research Corp. stock. Willis Investment Counsel purchased a new stake in shares of National Research Corp. (NASDAQ:NRCIB) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 13,329 shares of the company’s stock, valued at approximately $442,000. Willis Investment Counsel owned approximately 0.06% of National Research Corp. as of its most recent filing with the SEC. 2.90% of the stock is owned by institutional investors and hedge funds.

Separately, Zacks Investment Research upgraded National Research Corp. from a “hold” rating to a “buy” rating and set a $37.00 target price for the company in a research report on Friday, August 12th.

National Research Corp. Company Profile

National Research Corp. is a business services company in the Health Care Services industry.

5 Day Chart for NASDAQ:NRCIB

Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with's FREE daily email newsletter.